'Dangerous Drugs' Category
By Simmons Hanly Conroy | June 10, 2014
Testosterone Therapy Lawsuits Consolidated Before One Judge
The U.S. Judicial Panel on Multidistrict Litigation has ordered the consolidation of all federal testosterone therapy lawsuits before the Hon. Matthew F. Kennelly in the Northern District of Illinois, U.S. District Court.… Read More
By Simmons Hanly Conroy | May 7, 2014
FDA Moves Transvaginal Mesh Devices to ‘High Risk’ Category
The U.S. Food and Drug Administration recently submitted a federal proposal to establish stricter safety requirements for transvaginal surgical mesh implants. The devices are often used to repair pelvic collapse in women, and… Read More
By Simmons Hanly Conroy | April 22, 2014
The Psychological Effects of Gynecomastia Linked to Risperdal
A study conducted by the American Society of Plastic Surgeons (ASPS) and colleagues of Boston Children’s Hospital examined the mental and emotional effects of gynecomastia, a condition in which men develop female… Read More
By Simmons Hanly Conroy | April 16, 2014
Low Testosterone Diagnosis: Are Current Testing Methods Substantial?
Since 2000, the number of American men taking testosterone replacement therapy has quadrupled. More than 5 million prescriptions were written for testosterone therapy in 2011 alone. Men experience a decline in natural… Read More
By Simmons Hanly Conroy | April 16, 2014
Louisiana Jury Orders Actos Manufacturer to Pay $9 Billion
Takeda Pharmaceutical Co. and Eli Lilly & Co. have been ordered to pay a total of $9 billion in punitive damages in connection to the diabetes drug Actos. A Louisiana jury found… Read More
By Simmons Hanly Conroy | March 14, 2014
Consolidation of Lipitor Lawsuits to Streamline Process
Currently 56 personal injury claims regarding Lipitor have been filed. More than 170 similar federal cases are pending in more than 40 districts before 100 different judges. As a result, the U.S.… Read More
By Simmons Hanly Conroy | March 7, 2014
FDA Runs First Widespread Quality & Safety Evaluation on Generic Drugs
More than 80 percent of prescription drugs in the U.S. are being tested by the Food and Drug Administration (FDA) in its first widespread safety and quality evaluation. The effort will examine… Read More
By Simmons Hanly Conroy | February 28, 2014
Pharmaceutical News Wrap Up: February 2014
The pharmaceutical lawyers at the Firm are committed to keeping you up-to-date on the latest pharmaceutical news. Below is a short list of some of the most recent headlines concerning FDA recalls,… Read More
By Simmons Hanly Conroy | February 24, 2014
Studies Point to Inconsistencies in FDA Approval Process
Three new studies took a deeper look into the U.S. Food and Drug Administration (FDA) regulatory process. Results from the studies found that FDA approval does not necessarily mean the medication or… Read More
By Simmons Hanly Conroy | February 14, 2014
Study Finds Antioxidant Supplements May Accelerate Cancer Growth
Two antioxidants, vitamin E and beta carotene may do more harm than good in lung cancer patients, a new study suggests. Researchers showed that, antioxidants accelerated the progression of tumors in mice… Read More
